G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Taiwan · Delayed Price · Currency is TWD

28.40

-0.10 (-0.35%)

Sep 15, 2026, 1:30 PM CST

G&E Herbal Biotechnology Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	215.61	309.13	249.03	181.44	64.61	24.57
Revenue Growth	-26.73%	24.13%	37.25%	180.84%	162.94%	-12.96%
Gross Profit	173.54	263.22	205.34	144.59	39.35	9.63
Operating Income	82.92	152.3	119.65	80.68	5.49	-19.56
Net Income	86.25	139.2	102.06	72.4	7.38	-19.88
Earnings Per Share	1.25	2.02	1.48	1.05	0.11	-0.29
EPS Growth	-35.99%	36.25%	40.82%	901.00%	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	425.82	430.31	408.87	312.92	205.95	108.88
Total Debt	0.42	0.87	1.75	1.98	-	-
Net Cash (Debt)	425.4	429.44	407.13	310.94	205.95	108.88
Net Cash Growth	-5.87%	5.48%	30.93%	50.98%	89.15%	-9.31%
Net Cash Per Share	6.17	6.23	5.91	4.51	2.99	1.58

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	21.07	70.18	134.68	113.48	99.96	-9.19
Capital Expenditures	-2.96	-3.2	-5.92	-5.52	-2.95	-1.77
Free Cash Flow	18.11	66.98	128.76	107.96	97.01	-10.96
Free Cash Flow Growth	-88.81%	-47.98%	19.26%	11.29%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	80.49%	85.15%	82.46%	79.69%	60.91%	39.17%
Operating Margin	38.46%	49.27%	48.04%	44.47%	8.49%	-79.61%
Pretax Margin	41.40%	51.24%	50.08%	49.88%	11.19%	-74.16%
Profit Margin	40.00%	45.03%	40.98%	39.90%	11.42%	-80.92%
FCF Margin	8.40%	21.67%	51.70%	59.50%	150.15%	-44.61%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	1.080	1.080	0.704	0.461
Dividend Per Share Growth	66.38%	53.43%	52.65%	-
Dividend Yield	3.60%	2.81%	1.52%	0.98%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	22.81	19.64	32.72	47.51	402.69	-
P/FCF Ratio	100.27	40.82	25.94	31.86	30.64	-
PS Ratio	8.42	8.84	13.41	18.96	46.01	63.43